Results 171 to 180 of about 37,267 (288)

Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy. [PDF]

QJM
Kashio T, Horino T, Yagyu K, Osakabe Y, Inotani S, Terada Y.   +5 more
europepmc   +1 more source

Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation

, 2007
Vaishali Sanchorawala, Martha Skinner, Karen Quillen, Kathleen T. Finn, Gheorghe Doros, David C. Seldin   +5 more
openalex   +1 more source

Mapping VEXAS‐associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population

British Journal of Haematology, EarlyView.
VEXAS syndrome is a late‐onset inflammatory disorder with rheumatological and haematological features. Epidemiological studies of VEXAS syndrome so far have been limited. Analysis of various UK cohorts estimates the incidence of VEXAS to be 1.51/100 000, or 171 new cases in the population of men over the age of 50 who are being investigated for myeloid
Ana Martinez Rodriguez, Leon Chang, Dorota Rowczenio, Alexandra Smith, Ebun Omoyinmi, James A. Poulter, Andrew McGregor, Sebastian Francis, Roochi Trikha, Adam Al‐Hakim, Kar Lok Kong, David G. Kent, Helen Lachmann, Austin Kulasekararaj, Catherine Cargo, Sinisa Savic   +15 more
wiley   +1 more source

Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis. [PDF]

Br J Haematol
Khwaja J, Ravichandran S, Cohen O, Foard D, Low M, Martinez-Naharro A, Venneri L, Fontana M, Hawkins PN, Gillmore J, Lachmann HJ, Whelan C, Mahmood S, Wechalekar A.   +13 more
europepmc   +1 more source

Periorbital purpura of AL amyloidosis

Rheumatology, 2020
Michael Chen-Xu, Katerina Achilleos
openaire   +2 more sources

Primary myelofibrosis with increased haemoglobin concentration at presentation

British Journal of Haematology, EarlyView.
Subjects with primary myelofibrosis and elevated haemoglobin levels at diagnosis tend to have longer survival rates (OS) and blast transformation‐free survival (BTFS) than those with normal or reduced haemoglobin levels. Summary One hundred of 963 consecutive registrants with primary myelofibrosis (PMF) in the Pavia‐CSM database had haemoglobin ...
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Annalisa De Silvestri, Robert Peter Gale, Vittorio Rosti   +8 more
wiley   +1 more source

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study. [PDF]

Blood Adv
Song A, Mellgard G, Bellofiore C, Basset M, Nuvolone M, Foli A, Merlini G, Maurer MS, Mapara MY, Bhutani D, Lentzsch S, Shaish H, Palladini G, Chakraborty R, Milani P.   +14 more
europepmc   +1 more source

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

, 2007
Efstathios Kastritis, Αchilles Anagnostopoulos, Μαρία Ρούσσου, Savvas Toumanidis, Constantinos Pamboukas, Magdalini Migkou, Anna Tassidou, Irini Xilouri, Sossana Delibasi, Erasmia Psimenou, S. Mellou, Evangelos Terpos, J. Nanas, Meletios Α. Dimopoulos   +13 more
openalex   +2 more sources

Robot‐assisted vs open kidney transplantation from deceased donors

BJU International, EarlyView.
Objectives To test the hypothesis that the type of surgical approach, robot‐assisted kidney transplantation (RAKT) vs open kidney transplantation (OKT), impacts intra‐operative and postoperative surgical outcomes of patients receiving kidney transplantation from deceased donors.
Luca Afferi, Angelo Territo, Alessio Pecoraro, Lorenzo Masieri, Milla Ortved, Julia Abildgaard Dagnæs‐Hansen, Begonya Etcheverry, Andrea Gallioli, Donato Cannoletta, Joris Vangeneugden, Jeremy Mercier, Thomas Prudhomme, Isacco Donnini, Antonino Vazzana, Malene Rohrsted, Francesc Vigués, Nicolas Doumerc, Karel Decaestecker, Joan Palou, Riccardo Campi, Sergio Serni, Andreas Roder, Alberto Breda   +22 more
wiley   +1 more source

Validation of a renal staging system and its association with renal amyloid deposition burden in AL amyloidosis. [PDF]

Ren Fail
Yao Y, Wang S, Li DY, Yu XJ, Liu JY, Qiu ZX, Zhou FD, Wang SX.   +7 more
europepmc   +1 more source